AMBLER, PA--(MARKET WIRE)--Jul 6, 2006 -- QuantRx® Biomedical Corporation (OTC BB:QTXB.OB - News), announced the completion of a Worldwide Technology License Agreement with The Procter & Gamble Company (NYSE:PG - News). Walter Witoshkin, President and CEO, stated, “We are pleased to be able to add this significant technology as an expansion to our world-wide intellectual property. With the addition of this key technology to the QuantRx® PAD portfolio of products we plan to enter the hemorrhoid treatment market with great confidence in our competitive advantages.”
